Your session is about to expire
← Back to Search
Standardized Dialysis for Acute Kidney Injury (Recover-AKI Trial)
N/A
Recruiting
Led By Samuel A Silver
Research Sponsored by Samuel Silver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Plans for continued intermittent hemodialysis or sustained low efficiency dialysis treatments
Received ≥2 sessions of any dialysis modality for presumed AKI
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Recover-AKI Trial Summary
This trial will compare a standardized dialysis strategy to usual care in order to evaluate feasibility for AKI patients receiving dialysis.
Who is the study for?
This trial is for patients who have had acute kidney injury and received at least two dialysis sessions, with plans to continue. It's not for those on dialysis for over 90 days, with certain pre-existing conditions like severe chronic kidney disease or specific acute renal diseases, recent kidney transplant recipients, or pregnant individuals.Check my eligibility
What is being tested?
The study compares a standardized dialysis strategy (S2D2) against the usual care where each patient's primary nephrologist decides the treatment. The aim is to see if it's feasible to do a larger trial on this approach in patients recovering from acute kidney injury.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks of dialysis can include low blood pressure, muscle cramps, itching, sleep problems and infections. The structured approach may alter these risks but details would be provided during the consent process.
Recover-AKI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am planning to continue with my dialysis treatments.
Select...
I have undergone at least 2 dialysis treatments for acute kidney injury.
Recover-AKI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Fidelity
Recruitment
Secondary outcome measures
Dialysis-Free Days
Hypotensive Event on Dialysis
Other outcome measures
Arrhythmia on Dialysis
Recover-AKI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Standardized Dialysis and Structured Discontinuation (S2D2)Experimental Treatment1 Intervention
Prescription to minimize dialysis-induced ischemia and standardize dialysis discontinuation
Group II: Usual CareActive Control1 Intervention
Dialysis prescription ordered by their primary nephrologist/intensivist.
Find a Location
Who is running the clinical trial?
Samuel SilverLead Sponsor
1 Previous Clinical Trials
400 Total Patients Enrolled
Unity Health TorontoOTHER
539 Previous Clinical Trials
447,665 Total Patients Enrolled
5 Trials studying Acute Kidney Injury
3,522 Patients Enrolled for Acute Kidney Injury
Samuel A SilverPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
400 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am suspected to have a serious kidney condition causing my acute kidney injury.I am planning to continue with my dialysis treatments.I have not had dialysis in the last 2 months before this hospital visit.I have been on dialysis for at least 90 days.Your kidney function is severely reduced, based on a specific test called eGFR.I have undergone at least 2 dialysis treatments for acute kidney injury.I had a kidney transplant within the last year.
Research Study Groups:
This trial has the following groups:- Group 1: Standardized Dialysis and Structured Discontinuation (S2D2)
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this clinical experiment currently open?
"According to clinicaltrials.gov, this study is actively enrolling participants and has been since it was initially posted on April 12th 2022. It underwent its most recent revision on the 28th of that same month."
Answered by AI
What is the current participation rate of this experiment?
"Affirmative. The trial is currently in search of participants, as evidenced by information available on clinicaltrials.gov. This study was first made public on April 12th 2022 and has seen an update recently issued on April 28th 2022; it requires 100 recruits for its single medical centre location."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger